InvestorsHub Logo
Followers 92
Posts 3703
Boards Moderated 0
Alias Born 12/21/2017

Re: A deleted message

Tuesday, 10/13/2020 8:57:37 AM

Tuesday, October 13, 2020 8:57:37 AM

Post# of 35961
From 8k, a change in control has taken place:

https://www.sec.gov/Archives/edgar/data/1421204/000121390020030660/ea127966-8k_inspyrtherap.htm



As a result of the issuance of the Common Shares and Series F Preferred Stock, Ridgeway Therapeutics became the owner of approximately 54.14% of the Company’s issued and outstanding Common Stock. Furthermore, by virtue of the issuance of the Series F Preferred Stock, Ridgeway will vote on an as converted to common stock basis which shall be equal to eighty percent (80%) of the issued and outstanding Common Stock post-conversion. Accordingly, the board of directors of the Company has determined that a change in control of the registrant has occurred. The Company did not have a prior relationship with Ridgeway, or any of its principals, except pursuant to the terms contained in the Termination Agreement and its previous relationship under the Licensing Agreement.

This is getting serious. As of this point NSPX has only had an interim CEO, I expect more filings and a jump in share price.